Citations 2
CALGB 70604 (Alliance): A randomized phase III study of standard dosing vs. longer interval dosing of zoledronic acid in metastatic cancer.
Himelstein, Andrew L., Qin, Rui , Novotny, Paul J. , Seisler, Drew K., Khatcheressian, James, Roberts, John D. , Grubbs, Stephen S., Weckstein, Douglas, Loprinzi, Charles L. , O’Connor, Tracey L. , Shapiro, Charles L.
Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 9501-9501
Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases
Himelstein, Andrew L., Foster, Jared C. , Khatcheressian, James, Roberts, John D. , Seisler, Drew K., Novotny, Paul J. , Qin, Rui , Grubbs, Stephen S., O’Connor, Tracey L. , Velasco, Mario R. , Weckstein, Douglas, O’Mara, Ann M., Loprinzi, Charles L. , Go, Ronald S. , Shapiro, Charles L.
JAMA | January 5, 2017 | Volume: 317 | Issue: 1 | Pages: 48